# Amarantus Bioscience Holdings, Inc.: Form D filings

Amarantus Bioscience Holdings, Inc., a pharmaceuticals company in San Francisco, CA, filed 4 Form D notices with the SEC between 2013 and 2018. The latest, on March 12, 2018, reports $300,000 sold of a $1.5 million offering to 1 investor.

Find out what Amarantus Bioscience Holdings, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Amarantus%20Bioscience%20Holdings%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Amarantus%20Bioscience%20Holdings%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Famarantus-bioscience-holdings-inc-1424812)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Amarantus%20Bioscience%20Holdings%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Amarantus%20Bioscience%20Holdings%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Famarantus-bioscience-holdings-inc-1424812)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 953 INDIANA STREET, San Francisco, CA, 94104
- Phone: (917) 686-5317
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Nevada
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1424812

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 12, 2018 | New notice | $1,500,000 | $300,000 | $1,200,000 | 1 | Feb 26, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1424812/000121390018002828/0001213900-18-002828-index.htm) |
| Nov 17, 2014 | New notice | $3,000,000 | $3,000,000 | $0 | 1 | Nov 7, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1424812/000114420414069280/0001144204-14-069280-index.htm) |
| Sep 13, 2013 | New notice | $5,000,000 | $1,390,000 | $3,610,000 | 5 | Sep 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1424812/000114420413050679/0001144204-13-050679-index.htm) |
| Aug 28, 2013 | New notice | $1,299,327 | $1,299,327 | $0 | 1 | Aug 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1424812/000114420413048288/0001144204-13-048288-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Gerald Commissiong | Executive Officer, Director |  |
| Donald Huffman | Director |  |
| John Commissiong | Executive Officer, Director |  |
| Robert Harris | Director |  |
| Steven Spence | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Mar 12, 2018](https://specstream.ai/data/form-d/week/2018-03-12) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Amarantus Bioscience Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).